- advertisement -

Anyone sense a Capture and Kill scenario here?

Discussion in 'Research' started by fishface326, Jul 14, 2021.

  1. fishface326

    fishface326 Approved members

    Joined:
    Jun 5, 2018
    Messages:
    19
    gotta keep selling that old fashioned insulin to a captive marketplace - no need for anything new!

    Lilly Announces Acquisition of Protomer Technologies | State | kpcnews.com

    INDIANAPOLIS, July 14, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the acquisition of Protomer Technologies ("Protomer"), a private biotech company. Protomer's proprietary peptide- and protein-engineering platform is used to identify and synthesize molecules that can sense glucose or other endogenous modulators of protein activity.

    The potential value of the transaction is over $1 billion, with successful achievement of future development and commercial milestones. Lilly previously led an equity investment in Protomer alongside the JDRF T1D Fund, providing Lilly with 14 percent ownership of the company. Lilly is acquiring the remainder of the stock of Protomer beyond its initial investment.
     

Share This Page

- advertisement -

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice